Benjamin Garmezy, MD, explains what varying Nectin-4 expression means for treatment selection in bladder cancer and what trials are still needed.
Benjamin Garmezy, MD
Advertisement
Articles by Benjamin Garmezy, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Medicare Cap Eases Patient Costs as Negotiation Squeezes Practices
2
Access and Innovation in North Carolina’s Research Triangle
3
An Odyssey of Symptoms, Setbacks, Treatments, and a Cure With CAR T-Cell Therapy
4
PBM Satisfaction Stalls as Net Promoter Score Turns Negative
5